nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2E1—lung cancer	0.343	1	CbGaD
Thioridazine—CYP2C19—Gefitinib—lung cancer	0.0329	0.0973	CbGbCtD
Thioridazine—CYP2C19—Teniposide—lung cancer	0.0319	0.0943	CbGbCtD
Thioridazine—CYP2C9—Gefitinib—lung cancer	0.0273	0.0809	CbGbCtD
Thioridazine—CYP2C9—Teniposide—lung cancer	0.0265	0.0784	CbGbCtD
Thioridazine—CYP2D6—Gefitinib—lung cancer	0.025	0.074	CbGbCtD
Thioridazine—CYP2C8—Erlotinib—lung cancer	0.0232	0.0686	CbGbCtD
Thioridazine—CYP2E1—Etoposide—lung cancer	0.0224	0.0664	CbGbCtD
Thioridazine—CYP2C8—Paclitaxel—lung cancer	0.0212	0.0628	CbGbCtD
Thioridazine—CYP2D6—Vinorelbine—lung cancer	0.0192	0.057	CbGbCtD
Thioridazine—CYP1A2—Erlotinib—lung cancer	0.0179	0.0531	CbGbCtD
Thioridazine—CYP2C8—Etoposide—lung cancer	0.0167	0.0496	CbGbCtD
Thioridazine—CYP2C9—Paclitaxel—lung cancer	0.0148	0.0438	CbGbCtD
Thioridazine—CYP2D6—Erlotinib—lung cancer	0.0148	0.0437	CbGbCtD
Thioridazine—CYP1A2—Etoposide—lung cancer	0.013	0.0384	CbGbCtD
Thioridazine—CYP2C9—Cisplatin—lung cancer	0.0119	0.0352	CbGbCtD
Thioridazine—CYP2D6—Vinblastine—lung cancer	0.0119	0.0351	CbGbCtD
Thioridazine—HTR2A—phrenic nerve—lung cancer	0.00819	0.266	CbGeAlD
Thioridazine—CYP2D6—Doxorubicin—lung cancer	0.00729	0.0216	CbGbCtD
Thioridazine—HTR7—pulmonary artery—lung cancer	0.00477	0.155	CbGeAlD
Thioridazine—HTR2A—pulmonary artery—lung cancer	0.00297	0.0967	CbGeAlD
Thioridazine—CYP2C8—mammary gland—lung cancer	0.00103	0.0334	CbGeAlD
Thioridazine—CYP2C9—mammary gland—lung cancer	0.000911	0.0296	CbGeAlD
Thioridazine—HTR7—respiratory system—lung cancer	0.000802	0.0261	CbGeAlD
Thioridazine—DRD2—respiratory system—lung cancer	0.000758	0.0247	CbGeAlD
Thioridazine—HTR7—epithelium—lung cancer	0.00067	0.0218	CbGeAlD
Thioridazine—ADRA1A—epithelium—lung cancer	0.000646	0.021	CbGeAlD
Thioridazine—CYP1A2—respiratory system—lung cancer	0.000639	0.0208	CbGeAlD
Thioridazine—HRH1—respiratory system—lung cancer	0.000599	0.0195	CbGeAlD
Thioridazine—HTR7—trachea—lung cancer	0.000592	0.0193	CbGeAlD
Thioridazine—CYP2E1—respiratory system—lung cancer	0.000575	0.0187	CbGeAlD
Thioridazine—KCNH2—cardiac atrium—lung cancer	0.000518	0.0169	CbGeAlD
Thioridazine—HRH1—epithelium—lung cancer	0.0005	0.0163	CbGeAlD
Thioridazine—HTR2A—respiratory system—lung cancer	0.0005	0.0163	CbGeAlD
Thioridazine—ADRA2A—bronchus—lung cancer	0.000484	0.0157	CbGeAlD
Thioridazine—HRH1—trachea—lung cancer	0.000442	0.0144	CbGeAlD
Thioridazine—KCNH2—bone marrow—lung cancer	0.000438	0.0142	CbGeAlD
Thioridazine—ADRA2A—trachea—lung cancer	0.000434	0.0141	CbGeAlD
Thioridazine—Eletriptan—CYP2A6—lung cancer	0.000427	0.175	CrCbGaD
Thioridazine—HTR7—lung—lung cancer	0.000426	0.0139	CbGeAlD
Thioridazine—HTR2A—epithelium—lung cancer	0.000418	0.0136	CbGeAlD
Thioridazine—ADRA2A—cardiac atrium—lung cancer	0.000408	0.0133	CbGeAlD
Thioridazine—DRD2—lung—lung cancer	0.000402	0.0131	CbGeAlD
Thioridazine—HTR2A—trachea—lung cancer	0.000369	0.012	CbGeAlD
Thioridazine—CYP1A2—lung—lung cancer	0.00034	0.0111	CbGeAlD
Thioridazine—HRH1—lung—lung cancer	0.000318	0.0103	CbGeAlD
Thioridazine—Clomipramine—GSTP1—lung cancer	0.000315	0.129	CrCbGaD
Thioridazine—ADRA2A—lung—lung cancer	0.000312	0.0102	CbGeAlD
Thioridazine—Dermatitis—Teniposide—lung cancer	0.000312	0.00206	CcSEcCtD
Thioridazine—Feeling abnormal—Vinblastine—lung cancer	0.000311	0.00205	CcSEcCtD
Thioridazine—Constipation—Erlotinib—lung cancer	0.00031	0.00205	CcSEcCtD
Thioridazine—Headache—Teniposide—lung cancer	0.00031	0.00205	CcSEcCtD
Thioridazine—Dermatitis contact—Doxorubicin—lung cancer	0.000309	0.00204	CcSEcCtD
Thioridazine—Abnormal dreams—Doxorubicin—lung cancer	0.000309	0.00204	CcSEcCtD
Thioridazine—Erythema—Gemcitabine—lung cancer	0.000309	0.00204	CcSEcCtD
Thioridazine—Thrombocytopenia—Vinorelbine—lung cancer	0.000307	0.00203	CcSEcCtD
Thioridazine—Tachycardia—Vinorelbine—lung cancer	0.000306	0.00202	CcSEcCtD
Thioridazine—CYP2E1—lung—lung cancer	0.000305	0.00994	CbGeAlD
Thioridazine—Feeling abnormal—Topotecan—lung cancer	0.000302	0.00199	CcSEcCtD
Thioridazine—Anorexia—Vinorelbine—lung cancer	0.000299	0.00197	CcSEcCtD
Thioridazine—Photosensitivity—Methotrexate—lung cancer	0.000299	0.00197	CcSEcCtD
Thioridazine—Pancytopenia—Docetaxel—lung cancer	0.000299	0.00197	CcSEcCtD
Thioridazine—Arrhythmia—Cisplatin—lung cancer	0.000295	0.00195	CcSEcCtD
Thioridazine—Nausea—Teniposide—lung cancer	0.000294	0.00194	CcSEcCtD
Thioridazine—Aplastic anaemia—Doxorubicin—lung cancer	0.000294	0.00194	CcSEcCtD
Thioridazine—Hypotension—Vinorelbine—lung cancer	0.000293	0.00193	CcSEcCtD
Thioridazine—Anaemia—Irinotecan—lung cancer	0.000293	0.00193	CcSEcCtD
Thioridazine—Oedema peripheral—Paclitaxel—lung cancer	0.000293	0.00193	CcSEcCtD
Thioridazine—Body temperature increased—Topotecan—lung cancer	0.00029	0.00191	CcSEcCtD
Thioridazine—Erythema—Cisplatin—lung cancer	0.000288	0.0019	CcSEcCtD
Thioridazine—Body temperature increased—Erlotinib—lung cancer	0.000287	0.00189	CcSEcCtD
Thioridazine—Weight increased—Docetaxel—lung cancer	0.000286	0.00189	CcSEcCtD
Thioridazine—Anaemia—Gemcitabine—lung cancer	0.000285	0.00188	CcSEcCtD
Thioridazine—Leukopenia—Irinotecan—lung cancer	0.000284	0.00187	CcSEcCtD
Thioridazine—Hypersensitivity—Vinblastine—lung cancer	0.000278	0.00184	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000278	0.00183	CcSEcCtD
Thioridazine—Leukopenia—Gemcitabine—lung cancer	0.000276	0.00182	CcSEcCtD
Thioridazine—Jaundice—Docetaxel—lung cancer	0.000273	0.0018	CcSEcCtD
Thioridazine—Decreased appetite—Vinorelbine—lung cancer	0.000273	0.0018	CcSEcCtD
Thioridazine—Vision blurred—Cisplatin—lung cancer	0.000271	0.00179	CcSEcCtD
Thioridazine—KCNH2—lymph node—lung cancer	0.000271	0.00883	CbGeAlD
Thioridazine—Hypersensitivity—Topotecan—lung cancer	0.00027	0.00178	CcSEcCtD
Thioridazine—Tremor—Cisplatin—lung cancer	0.00027	0.00178	CcSEcCtD
Thioridazine—Constipation—Vinorelbine—lung cancer	0.000268	0.00177	CcSEcCtD
Thioridazine—Lethargy—Methotrexate—lung cancer	0.000268	0.00177	CcSEcCtD
Thioridazine—Anaemia—Cisplatin—lung cancer	0.000266	0.00176	CcSEcCtD
Thioridazine—HTR2A—lung—lung cancer	0.000265	0.00864	CbGeAlD
Thioridazine—Arrhythmia—Paclitaxel—lung cancer	0.000265	0.00175	CcSEcCtD
Thioridazine—Agranulocytosis—Docetaxel—lung cancer	0.000262	0.00173	CcSEcCtD
Thioridazine—Confusional state—Irinotecan—lung cancer	0.000261	0.00172	CcSEcCtD
Thioridazine—Mental disorder—Paclitaxel—lung cancer	0.00026	0.00172	CcSEcCtD
Thioridazine—Oedema—Irinotecan—lung cancer	0.000259	0.00171	CcSEcCtD
Thioridazine—Photosensitivity—Doxorubicin—lung cancer	0.000259	0.00171	CcSEcCtD
Thioridazine—Erythema—Paclitaxel—lung cancer	0.000259	0.00171	CcSEcCtD
Thioridazine—Feeling abnormal—Vinorelbine—lung cancer	0.000259	0.00171	CcSEcCtD
Thioridazine—Diarrhoea—Vinblastine—lung cancer	0.000258	0.0017	CcSEcCtD
Thioridazine—Leukopenia—Cisplatin—lung cancer	0.000258	0.0017	CcSEcCtD
Thioridazine—Thrombocytopenia—Irinotecan—lung cancer	0.000253	0.00167	CcSEcCtD
Thioridazine—Oedema—Gemcitabine—lung cancer	0.000252	0.00166	CcSEcCtD
Thioridazine—Diarrhoea—Topotecan—lung cancer	0.000251	0.00166	CcSEcCtD
Thioridazine—Hyperhidrosis—Irinotecan—lung cancer	0.00025	0.00165	CcSEcCtD
Thioridazine—Diarrhoea—Erlotinib—lung cancer	0.000248	0.00164	CcSEcCtD
Thioridazine—Body temperature increased—Vinorelbine—lung cancer	0.000248	0.00164	CcSEcCtD
Thioridazine—Oedema peripheral—Docetaxel—lung cancer	0.000248	0.00164	CcSEcCtD
Thioridazine—Thrombocytopenia—Gemcitabine—lung cancer	0.000247	0.00163	CcSEcCtD
Thioridazine—Anorexia—Irinotecan—lung cancer	0.000247	0.00163	CcSEcCtD
Thioridazine—Anaemia—Etoposide—lung cancer	0.000244	0.00161	CcSEcCtD
Thioridazine—Vision blurred—Paclitaxel—lung cancer	0.000244	0.00161	CcSEcCtD
Thioridazine—Hyperhidrosis—Gemcitabine—lung cancer	0.000244	0.00161	CcSEcCtD
Thioridazine—Tremor—Paclitaxel—lung cancer	0.000242	0.0016	CcSEcCtD
Thioridazine—Hypotension—Irinotecan—lung cancer	0.000242	0.0016	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000241	0.00159	CcSEcCtD
Thioridazine—Anorexia—Gemcitabine—lung cancer	0.00024	0.00159	CcSEcCtD
Thioridazine—Vomiting—Vinblastine—lung cancer	0.00024	0.00158	CcSEcCtD
Thioridazine—Anaemia—Paclitaxel—lung cancer	0.000239	0.00158	CcSEcCtD
Thioridazine—Agitation—Paclitaxel—lung cancer	0.000238	0.00157	CcSEcCtD
Thioridazine—Headache—Vinblastine—lung cancer	0.000237	0.00156	CcSEcCtD
Thioridazine—Angioedema—Paclitaxel—lung cancer	0.000236	0.00156	CcSEcCtD
Thioridazine—Leukopenia—Etoposide—lung cancer	0.000236	0.00156	CcSEcCtD
Thioridazine—Hypotension—Gemcitabine—lung cancer	0.000236	0.00155	CcSEcCtD
Thioridazine—Oedema—Cisplatin—lung cancer	0.000235	0.00155	CcSEcCtD
Thioridazine—Vomiting—Topotecan—lung cancer	0.000233	0.00154	CcSEcCtD
Thioridazine—Lethargy—Doxorubicin—lung cancer	0.000232	0.00153	CcSEcCtD
Thioridazine—Leukopenia—Paclitaxel—lung cancer	0.000231	0.00153	CcSEcCtD
Thioridazine—Rash—Topotecan—lung cancer	0.000231	0.00153	CcSEcCtD
Thioridazine—Hypersensitivity—Vinorelbine—lung cancer	0.000231	0.00153	CcSEcCtD
Thioridazine—Dermatitis—Topotecan—lung cancer	0.000231	0.00152	CcSEcCtD
Thioridazine—Vomiting—Erlotinib—lung cancer	0.000231	0.00152	CcSEcCtD
Thioridazine—Somnolence—Irinotecan—lung cancer	0.00023	0.00152	CcSEcCtD
Thioridazine—Thrombocytopenia—Cisplatin—lung cancer	0.00023	0.00152	CcSEcCtD
Thioridazine—Headache—Topotecan—lung cancer	0.00023	0.00152	CcSEcCtD
Thioridazine—Tachycardia—Cisplatin—lung cancer	0.000229	0.00151	CcSEcCtD
Thioridazine—Rash—Erlotinib—lung cancer	0.000229	0.00151	CcSEcCtD
Thioridazine—Dermatitis—Erlotinib—lung cancer	0.000229	0.00151	CcSEcCtD
Thioridazine—Headache—Erlotinib—lung cancer	0.000227	0.0015	CcSEcCtD
Thioridazine—Hyperhidrosis—Cisplatin—lung cancer	0.000227	0.0015	CcSEcCtD
Thioridazine—Asthma—Methotrexate—lung cancer	0.000227	0.0015	CcSEcCtD
Thioridazine—Decreased appetite—Irinotecan—lung cancer	0.000225	0.00148	CcSEcCtD
Thioridazine—Arrhythmia—Docetaxel—lung cancer	0.000225	0.00148	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—lung cancer	0.000224	0.00148	CcSEcCtD
Thioridazine—Nausea—Vinblastine—lung cancer	0.000224	0.00148	CcSEcCtD
Thioridazine—Somnolence—Gemcitabine—lung cancer	0.000224	0.00148	CcSEcCtD
Thioridazine—Anorexia—Cisplatin—lung cancer	0.000224	0.00148	CcSEcCtD
Thioridazine—Constipation—Irinotecan—lung cancer	0.000221	0.00146	CcSEcCtD
Thioridazine—Mental disorder—Docetaxel—lung cancer	0.000221	0.00146	CcSEcCtD
Thioridazine—Hypotension—Cisplatin—lung cancer	0.00022	0.00145	CcSEcCtD
Thioridazine—Erythema—Docetaxel—lung cancer	0.000219	0.00145	CcSEcCtD
Thioridazine—Decreased appetite—Gemcitabine—lung cancer	0.000219	0.00145	CcSEcCtD
Thioridazine—Nausea—Topotecan—lung cancer	0.000218	0.00144	CcSEcCtD
Thioridazine—HRH1—lymph node—lung cancer	0.000217	0.00708	CbGeAlD
Thioridazine—Confusional state—Etoposide—lung cancer	0.000217	0.00143	CcSEcCtD
Thioridazine—Cardiac arrest—Doxorubicin—lung cancer	0.000216	0.00143	CcSEcCtD
Thioridazine—Constipation—Gemcitabine—lung cancer	0.000216	0.00142	CcSEcCtD
Thioridazine—Nausea—Erlotinib—lung cancer	0.000216	0.00142	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—lung cancer	0.000215	0.00142	CcSEcCtD
Thioridazine—Diarrhoea—Vinorelbine—lung cancer	0.000215	0.00142	CcSEcCtD
Thioridazine—ADRA2A—lymph node—lung cancer	0.000214	0.00695	CbGeAlD
Thioridazine—Feeling abnormal—Irinotecan—lung cancer	0.000213	0.00141	CcSEcCtD
Thioridazine—Confusional state—Paclitaxel—lung cancer	0.000213	0.0014	CcSEcCtD
Thioridazine—Oedema—Paclitaxel—lung cancer	0.000211	0.00139	CcSEcCtD
Thioridazine—Thrombocytopenia—Etoposide—lung cancer	0.000211	0.00139	CcSEcCtD
Thioridazine—Tachycardia—Etoposide—lung cancer	0.00021	0.00139	CcSEcCtD
Thioridazine—Hyperhidrosis—Etoposide—lung cancer	0.000208	0.00137	CcSEcCtD
Thioridazine—Feeling abnormal—Gemcitabine—lung cancer	0.000208	0.00137	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—lung cancer	0.000207	0.00137	CcSEcCtD
Thioridazine—Thrombocytopenia—Paclitaxel—lung cancer	0.000207	0.00136	CcSEcCtD
Thioridazine—Tachycardia—Paclitaxel—lung cancer	0.000206	0.00136	CcSEcCtD
Thioridazine—Anorexia—Etoposide—lung cancer	0.000205	0.00135	CcSEcCtD
Thioridazine—Body temperature increased—Irinotecan—lung cancer	0.000205	0.00135	CcSEcCtD
Thioridazine—Decreased appetite—Cisplatin—lung cancer	0.000204	0.00135	CcSEcCtD
Thioridazine—Hyperhidrosis—Paclitaxel—lung cancer	0.000204	0.00135	CcSEcCtD
Thioridazine—Anaemia—Docetaxel—lung cancer	0.000203	0.00134	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—lung cancer	0.000202	0.00133	CcSEcCtD
Thioridazine—Anorexia—Paclitaxel—lung cancer	0.000201	0.00133	CcSEcCtD
Thioridazine—Hypotension—Etoposide—lung cancer	0.000201	0.00133	CcSEcCtD
Thioridazine—Vomiting—Vinorelbine—lung cancer	0.0002	0.00132	CcSEcCtD
Thioridazine—Body temperature increased—Gemcitabine—lung cancer	0.000199	0.00131	CcSEcCtD
Thioridazine—Rash—Vinorelbine—lung cancer	0.000198	0.00131	CcSEcCtD
Thioridazine—Dermatitis—Vinorelbine—lung cancer	0.000198	0.0013	CcSEcCtD
Thioridazine—Hypotension—Paclitaxel—lung cancer	0.000197	0.0013	CcSEcCtD
Thioridazine—Headache—Vinorelbine—lung cancer	0.000197	0.0013	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—lung cancer	0.000196	0.0013	CcSEcCtD
Thioridazine—Leukopenia—Docetaxel—lung cancer	0.000196	0.00129	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—lung cancer	0.000194	0.00128	CcSEcCtD
Thioridazine—Feeling abnormal—Cisplatin—lung cancer	0.000194	0.00128	CcSEcCtD
Thioridazine—Somnolence—Etoposide—lung cancer	0.000191	0.00126	CcSEcCtD
Thioridazine—Hypersensitivity—Irinotecan—lung cancer	0.000191	0.00126	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—lung cancer	0.000189	0.00124	CcSEcCtD
Thioridazine—Somnolence—Paclitaxel—lung cancer	0.000188	0.00124	CcSEcCtD
Thioridazine—Decreased appetite—Etoposide—lung cancer	0.000187	0.00123	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—lung cancer	0.000186	0.00123	CcSEcCtD
Thioridazine—Nausea—Vinorelbine—lung cancer	0.000186	0.00123	CcSEcCtD
Thioridazine—Body temperature increased—Cisplatin—lung cancer	0.000186	0.00123	CcSEcCtD
Thioridazine—Constipation—Etoposide—lung cancer	0.000184	0.00121	CcSEcCtD
Thioridazine—Decreased appetite—Paclitaxel—lung cancer	0.000183	0.00121	CcSEcCtD
Thioridazine—Constipation—Paclitaxel—lung cancer	0.00018	0.00119	CcSEcCtD
Thioridazine—Confusional state—Docetaxel—lung cancer	0.00018	0.00119	CcSEcCtD
Thioridazine—Photosensitivity reaction—Doxorubicin—lung cancer	0.000179	0.00118	CcSEcCtD
Thioridazine—Oedema—Docetaxel—lung cancer	0.000179	0.00118	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—lung cancer	0.000179	0.00118	CcSEcCtD
Thioridazine—Feeling abnormal—Etoposide—lung cancer	0.000177	0.00117	CcSEcCtD
Thioridazine—Diarrhoea—Irinotecan—lung cancer	0.000177	0.00117	CcSEcCtD
Thioridazine—Fluphenazine—CYP2E1—lung cancer	0.000177	0.0723	CrCbGaD
Thioridazine—Thrombocytopenia—Docetaxel—lung cancer	0.000175	0.00116	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—lung cancer	0.000175	0.00116	CcSEcCtD
Thioridazine—Tachycardia—Docetaxel—lung cancer	0.000175	0.00115	CcSEcCtD
Thioridazine—Feeling abnormal—Paclitaxel—lung cancer	0.000174	0.00115	CcSEcCtD
Thioridazine—Hypersensitivity—Cisplatin—lung cancer	0.000173	0.00114	CcSEcCtD
Thioridazine—Diarrhoea—Gemcitabine—lung cancer	0.000172	0.00114	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—lung cancer	0.000171	0.00113	CcSEcCtD
Thioridazine—Anorexia—Docetaxel—lung cancer	0.000171	0.00113	CcSEcCtD
Thioridazine—Body temperature increased—Etoposide—lung cancer	0.00017	0.00112	CcSEcCtD
Thioridazine—Hypotension—Docetaxel—lung cancer	0.000167	0.0011	CcSEcCtD
Thioridazine—Body temperature increased—Paclitaxel—lung cancer	0.000167	0.0011	CcSEcCtD
Thioridazine—Vomiting—Irinotecan—lung cancer	0.000165	0.00109	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—lung cancer	0.000163	0.00108	CcSEcCtD
Thioridazine—Rash—Irinotecan—lung cancer	0.000163	0.00108	CcSEcCtD
Thioridazine—Dermatitis—Irinotecan—lung cancer	0.000163	0.00108	CcSEcCtD
Thioridazine—Headache—Irinotecan—lung cancer	0.000162	0.00107	CcSEcCtD
Thioridazine—Diarrhoea—Cisplatin—lung cancer	0.000161	0.00106	CcSEcCtD
Thioridazine—Vomiting—Gemcitabine—lung cancer	0.00016	0.00106	CcSEcCtD
Thioridazine—Somnolence—Docetaxel—lung cancer	0.000159	0.00105	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—lung cancer	0.000159	0.00105	CcSEcCtD
Thioridazine—Rash—Gemcitabine—lung cancer	0.000159	0.00105	CcSEcCtD
Thioridazine—Eletriptan—ABCB1—lung cancer	0.000159	0.065	CrCbGaD
Thioridazine—Dermatitis—Gemcitabine—lung cancer	0.000159	0.00105	CcSEcCtD
Thioridazine—Hypersensitivity—Etoposide—lung cancer	0.000159	0.00105	CcSEcCtD
Thioridazine—Erythema—Methotrexate—lung cancer	0.000158	0.00104	CcSEcCtD
Thioridazine—Headache—Gemcitabine—lung cancer	0.000158	0.00104	CcSEcCtD
Thioridazine—Decreased appetite—Docetaxel—lung cancer	0.000156	0.00103	CcSEcCtD
Thioridazine—Hypersensitivity—Paclitaxel—lung cancer	0.000156	0.00103	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—lung cancer	0.000155	0.00102	CcSEcCtD
Thioridazine—Nausea—Irinotecan—lung cancer	0.000154	0.00101	CcSEcCtD
Thioridazine—Constipation—Docetaxel—lung cancer	0.000153	0.00101	CcSEcCtD
Thioridazine—Nausea—Gemcitabine—lung cancer	0.00015	0.000988	CcSEcCtD
Thioridazine—Vomiting—Cisplatin—lung cancer	0.000149	0.000986	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—lung cancer	0.000149	0.000982	CcSEcCtD
Thioridazine—Rash—Cisplatin—lung cancer	0.000148	0.000977	CcSEcCtD
Thioridazine—Dermatitis—Cisplatin—lung cancer	0.000148	0.000977	CcSEcCtD
Thioridazine—Feeling abnormal—Docetaxel—lung cancer	0.000147	0.000973	CcSEcCtD
Thioridazine—Diarrhoea—Etoposide—lung cancer	0.000147	0.000972	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—lung cancer	0.000146	0.000963	CcSEcCtD
Thioridazine—Methotrimeprazine—CYP2E1—lung cancer	0.000145	0.0595	CrCbGaD
Thioridazine—Diarrhoea—Paclitaxel—lung cancer	0.000144	0.000953	CcSEcCtD
Thioridazine—Body temperature increased—Docetaxel—lung cancer	0.000141	0.000933	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—lung cancer	0.000141	0.000933	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—lung cancer	0.00014	0.000926	CcSEcCtD
Thioridazine—Nausea—Cisplatin—lung cancer	0.00014	0.000921	CcSEcCtD
Thioridazine—Mental disorder—Doxorubicin—lung cancer	0.000138	0.000908	CcSEcCtD
Thioridazine—Vomiting—Etoposide—lung cancer	0.000137	0.000903	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—lung cancer	0.000137	0.000903	CcSEcCtD
Thioridazine—Rash—Etoposide—lung cancer	0.000136	0.000896	CcSEcCtD
Thioridazine—Dermatitis—Etoposide—lung cancer	0.000136	0.000895	CcSEcCtD
Thioridazine—Headache—Etoposide—lung cancer	0.000135	0.00089	CcSEcCtD
Thioridazine—Vomiting—Paclitaxel—lung cancer	0.000134	0.000885	CcSEcCtD
Thioridazine—Rash—Paclitaxel—lung cancer	0.000133	0.000878	CcSEcCtD
Thioridazine—Dermatitis—Paclitaxel—lung cancer	0.000133	0.000877	CcSEcCtD
Thioridazine—Headache—Paclitaxel—lung cancer	0.000132	0.000872	CcSEcCtD
Thioridazine—Hypersensitivity—Docetaxel—lung cancer	0.000132	0.00087	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—lung cancer	0.00013	0.000858	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—lung cancer	0.000129	0.000851	CcSEcCtD
Thioridazine—Nausea—Etoposide—lung cancer	0.000128	0.000844	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—lung cancer	0.000126	0.000834	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—lung cancer	0.000126	0.000833	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—lung cancer	0.000126	0.000829	CcSEcCtD
Thioridazine—Nausea—Paclitaxel—lung cancer	0.000125	0.000827	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—lung cancer	0.000125	0.000822	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—lung cancer	0.000123	0.000811	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—lung cancer	0.000122	0.000808	CcSEcCtD
Thioridazine—Diarrhoea—Docetaxel—lung cancer	0.000122	0.000808	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—lung cancer	0.00012	0.000795	CcSEcCtD
Thioridazine—Triflupromazine—ABCB1—lung cancer	0.00012	0.0493	CrCbGaD
Thioridazine—Acepromazine—ALB—lung cancer	0.000117	0.0478	CrCbGaD
Thioridazine—Somnolence—Methotrexate—lung cancer	0.000115	0.000756	CcSEcCtD
Thioridazine—Thioproperazine—ALB—lung cancer	0.000114	0.0467	CrCbGaD
Thioridazine—Vomiting—Docetaxel—lung cancer	0.000114	0.00075	CcSEcCtD
Thioridazine—Rash—Docetaxel—lung cancer	0.000113	0.000744	CcSEcCtD
Thioridazine—Dermatitis—Docetaxel—lung cancer	0.000113	0.000744	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—lung cancer	0.000113	0.000743	CcSEcCtD
Thioridazine—Pipotiazine—ALB—lung cancer	0.000112	0.046	CrCbGaD
Thioridazine—Thiothixene—ALB—lung cancer	0.000112	0.046	CrCbGaD
Thioridazine—Decreased appetite—Methotrexate—lung cancer	0.000112	0.00074	CcSEcCtD
Thioridazine—Headache—Docetaxel—lung cancer	0.000112	0.000739	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—lung cancer	0.000112	0.000737	CcSEcCtD
Thioridazine—Chlorpromazine—CYP2E1—lung cancer	0.000111	0.0454	CrCbGaD
Thioridazine—Thrombocytopenia—Doxorubicin—lung cancer	0.000109	0.000721	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—lung cancer	0.000109	0.000719	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—lung cancer	0.000108	0.000712	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—lung cancer	0.000106	0.000702	CcSEcCtD
Thioridazine—Nausea—Docetaxel—lung cancer	0.000106	0.000701	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—lung cancer	0.000106	0.000701	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—lung cancer	0.000104	0.000688	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—lung cancer	0.000102	0.000673	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—lung cancer	9.93e-05	0.000655	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—lung cancer	9.71e-05	0.00064	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—lung cancer	9.55e-05	0.00063	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—lung cancer	9.5e-05	0.000627	CcSEcCtD
Thioridazine—Fluphenazine—ABCB1—lung cancer	9.26e-05	0.0379	CrCbGaD
Thioridazine—Feeling abnormal—Doxorubicin—lung cancer	9.2e-05	0.000607	CcSEcCtD
Thioridazine—Clomipramine—ALB—lung cancer	8.87e-05	0.0363	CrCbGaD
Thioridazine—Body temperature increased—Doxorubicin—lung cancer	8.83e-05	0.000582	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—lung cancer	8.82e-05	0.000582	CcSEcCtD
Thioridazine—Clomipramine—ABCB1—lung cancer	8.47e-05	0.0347	CrCbGaD
Thioridazine—Hypersensitivity—Doxorubicin—lung cancer	8.23e-05	0.000543	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—lung cancer	8.2e-05	0.000541	CcSEcCtD
Thioridazine—Rash—Methotrexate—lung cancer	8.13e-05	0.000536	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—lung cancer	8.12e-05	0.000536	CcSEcCtD
Thioridazine—Headache—Methotrexate—lung cancer	8.08e-05	0.000533	CcSEcCtD
Thioridazine—Nausea—Methotrexate—lung cancer	7.66e-05	0.000505	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—lung cancer	7.64e-05	0.000504	CcSEcCtD
Thioridazine—Promethazine—ABCB1—lung cancer	7.5e-05	0.0307	CrCbGaD
Thioridazine—Trifluoperazine—ABCB1—lung cancer	7.4e-05	0.0303	CrCbGaD
Thioridazine—Vomiting—Doxorubicin—lung cancer	7.1e-05	0.000468	CcSEcCtD
Thioridazine—Rash—Doxorubicin—lung cancer	7.04e-05	0.000464	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—lung cancer	7.03e-05	0.000464	CcSEcCtD
Thioridazine—Headache—Doxorubicin—lung cancer	6.99e-05	0.000461	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—lung cancer	6.63e-05	0.000438	CcSEcCtD
Thioridazine—Chlorpromazine—ALB—lung cancer	6.09e-05	0.0249	CrCbGaD
Thioridazine—Chlorpromazine—ABCB1—lung cancer	5.81e-05	0.0238	CrCbGaD
Thioridazine—HTR6—Signaling Pathways—TP53—lung cancer	4.12e-06	3.07e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	4.12e-06	3.07e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—lung cancer	4.11e-06	3.07e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—lung cancer	4.11e-06	3.06e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—lung cancer	4.1e-06	3.06e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—lung cancer	4.1e-06	3.06e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—lung cancer	4.1e-06	3.05e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—lung cancer	4.09e-06	3.05e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—lung cancer	4.08e-06	3.04e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—lung cancer	4.07e-06	3.04e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—lung cancer	4.07e-06	3.04e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—lung cancer	4.06e-06	3.03e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MTOR—lung cancer	4.06e-06	3.03e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	4.06e-06	3.03e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	4.06e-06	3.03e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EP300—lung cancer	4.06e-06	3.03e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—JUN—lung cancer	4.05e-06	3.02e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—lung cancer	4.03e-06	3.01e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—lung cancer	4.03e-06	3.01e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—lung cancer	4.03e-06	3e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—lung cancer	4.02e-06	3e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—lung cancer	4.01e-06	2.99e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—lung cancer	4.01e-06	2.99e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—lung cancer	4.01e-06	2.99e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—EP300—lung cancer	4e-06	2.99e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—lung cancer	4e-06	2.98e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—lung cancer	3.99e-06	2.98e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—lung cancer	3.99e-06	2.98e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—JUN—lung cancer	3.99e-06	2.98e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—lung cancer	3.99e-06	2.98e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—lung cancer	3.99e-06	2.97e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—lung cancer	3.98e-06	2.97e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—JUN—lung cancer	3.98e-06	2.97e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—lung cancer	3.97e-06	2.96e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—lung cancer	3.96e-06	2.96e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CD—lung cancer	3.95e-06	2.95e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SRC—lung cancer	3.94e-06	2.94e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—lung cancer	3.94e-06	2.94e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—lung cancer	3.94e-06	2.94e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—lung cancer	3.93e-06	2.93e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—POMC—lung cancer	3.93e-06	2.93e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CDKN1A—lung cancer	3.93e-06	2.93e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—lung cancer	3.92e-06	2.93e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—lung cancer	3.92e-06	2.92e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—JUN—lung cancer	3.92e-06	2.92e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—lung cancer	3.91e-06	2.92e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—JUN—lung cancer	3.91e-06	2.91e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	3.9e-06	2.91e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—POMC—lung cancer	3.9e-06	2.91e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—lung cancer	3.9e-06	2.91e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—lung cancer	3.88e-06	2.89e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	3.88e-06	2.89e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—lung cancer	3.87e-06	2.89e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDKN1A—lung cancer	3.87e-06	2.88e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDKN1A—lung cancer	3.86e-06	2.88e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—lung cancer	3.86e-06	2.88e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CB—lung cancer	3.86e-06	2.88e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—lung cancer	3.85e-06	2.88e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—lung cancer	3.85e-06	2.87e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	3.84e-06	2.87e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—APOA1—lung cancer	3.83e-06	2.86e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CREBBP—lung cancer	3.83e-06	2.86e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—lung cancer	3.83e-06	2.85e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—lung cancer	3.82e-06	2.85e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK3—lung cancer	3.82e-06	2.85e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—lung cancer	3.81e-06	2.84e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—lung cancer	3.8e-06	2.84e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—lung cancer	3.8e-06	2.83e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CREBBP—lung cancer	3.8e-06	2.83e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1A—lung cancer	3.8e-06	2.83e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK3—lung cancer	3.8e-06	2.83e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—lung cancer	3.79e-06	2.83e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—lung cancer	3.79e-06	2.83e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	3.79e-06	2.82e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—lung cancer	3.78e-06	2.82e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	3.77e-06	2.81e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—lung cancer	3.77e-06	2.81e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—lung cancer	3.76e-06	2.81e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—lung cancer	3.76e-06	2.81e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—lung cancer	3.76e-06	2.8e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EP300—lung cancer	3.74e-06	2.79e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—lung cancer	3.74e-06	2.79e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—lung cancer	3.73e-06	2.78e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—lung cancer	3.71e-06	2.77e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—lung cancer	3.71e-06	2.77e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—lung cancer	3.7e-06	2.76e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—lung cancer	3.69e-06	2.75e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	3.69e-06	2.75e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EP300—lung cancer	3.68e-06	2.74e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—EP300—lung cancer	3.68e-06	2.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EP300—lung cancer	3.67e-06	2.74e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.67e-06	2.74e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—lung cancer	3.66e-06	2.73e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—lung cancer	3.64e-06	2.71e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SRC—lung cancer	3.64e-06	2.71e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	3.63e-06	2.71e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CD—lung cancer	3.63e-06	2.71e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—lung cancer	3.63e-06	2.71e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—JUN—lung cancer	3.63e-06	2.71e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EP300—lung cancer	3.61e-06	2.69e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—lung cancer	3.61e-06	2.69e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EP300—lung cancer	3.6e-06	2.69e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CD—lung cancer	3.6e-06	2.69e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—lung cancer	3.58e-06	2.67e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SRC—lung cancer	3.58e-06	2.67e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SRC—lung cancer	3.57e-06	2.66e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—lung cancer	3.55e-06	2.65e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—lung cancer	3.54e-06	2.64e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—lung cancer	3.54e-06	2.64e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—lung cancer	3.53e-06	2.64e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—lung cancer	3.53e-06	2.63e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	3.52e-06	2.62e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SRC—lung cancer	3.51e-06	2.62e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—lung cancer	3.51e-06	2.62e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—lung cancer	3.51e-06	2.62e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SRC—lung cancer	3.5e-06	2.61e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—lung cancer	3.5e-06	2.61e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—lung cancer	3.5e-06	2.61e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—lung cancer	3.48e-06	2.6e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—lung cancer	3.48e-06	2.59e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—lung cancer	3.48e-06	2.59e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—lung cancer	3.47e-06	2.59e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—lung cancer	3.46e-06	2.58e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—lung cancer	3.45e-06	2.57e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—lung cancer	3.44e-06	2.57e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—lung cancer	3.44e-06	2.57e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CB—lung cancer	3.44e-06	2.57e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—lung cancer	3.43e-06	2.56e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—lung cancer	3.43e-06	2.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	3.42e-06	2.55e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—lung cancer	3.42e-06	2.55e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	3.41e-06	2.55e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—lung cancer	3.41e-06	2.54e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—lung cancer	3.41e-06	2.54e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—lung cancer	3.39e-06	2.53e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—lung cancer	3.39e-06	2.53e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—lung cancer	3.38e-06	2.52e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—lung cancer	3.38e-06	2.52e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—lung cancer	3.37e-06	2.51e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK3—lung cancer	3.35e-06	2.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EP300—lung cancer	3.35e-06	2.5e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—lung cancer	3.33e-06	2.49e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—POMC—lung cancer	3.33e-06	2.48e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK3—lung cancer	3.3e-06	2.46e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK3—lung cancer	3.29e-06	2.45e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—lung cancer	3.27e-06	2.44e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—lung cancer	3.26e-06	2.43e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SRC—lung cancer	3.25e-06	2.43e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CREBBP—lung cancer	3.24e-06	2.42e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—lung cancer	3.24e-06	2.42e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK3—lung cancer	3.24e-06	2.41e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	3.23e-06	2.41e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—lung cancer	3.21e-06	2.39e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—lung cancer	3.2e-06	2.39e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—lung cancer	3.19e-06	2.38e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—EP300—lung cancer	3.18e-06	2.37e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	3.17e-06	2.36e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CB—lung cancer	3.17e-06	2.36e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	3.15e-06	2.35e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—lung cancer	3.15e-06	2.35e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—lung cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—lung cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CB—lung cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—lung cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—lung cancer	3.14e-06	2.34e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	3.13e-06	2.34e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—lung cancer	3.13e-06	2.34e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—lung cancer	3.13e-06	2.33e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—lung cancer	3.11e-06	2.32e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—lung cancer	3.08e-06	2.3e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CD—lung cancer	3.08e-06	2.29e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—lung cancer	3.07e-06	2.29e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—lung cancer	3.05e-06	2.27e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—lung cancer	3.04e-06	2.27e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—lung cancer	3.03e-06	2.26e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—lung cancer	3.01e-06	2.25e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	3e-06	2.24e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	3e-06	2.24e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—lung cancer	2.99e-06	2.23e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—lung cancer	2.97e-06	2.22e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—lung cancer	2.96e-06	2.21e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—lung cancer	2.96e-06	2.21e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—lung cancer	2.96e-06	2.21e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—lung cancer	2.92e-06	2.18e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—lung cancer	2.91e-06	2.17e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—lung cancer	2.91e-06	2.17e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—lung cancer	2.9e-06	2.17e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—lung cancer	2.9e-06	2.16e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—lung cancer	2.9e-06	2.16e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—lung cancer	2.85e-06	2.13e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—EP300—lung cancer	2.84e-06	2.12e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—lung cancer	2.79e-06	2.08e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—lung cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—lung cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.77e-06	2.06e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—lung cancer	2.74e-06	2.04e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	2.72e-06	2.03e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—lung cancer	2.72e-06	2.03e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—lung cancer	2.72e-06	2.03e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—lung cancer	2.71e-06	2.02e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.7e-06	2.01e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CB—lung cancer	2.68e-06	2e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—lung cancer	2.68e-06	2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	2.67e-06	1.99e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	2.66e-06	1.99e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—lung cancer	2.66e-06	1.98e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—lung cancer	2.66e-06	1.98e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—lung cancer	2.63e-06	1.96e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—lung cancer	2.63e-06	1.96e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—EP300—lung cancer	2.61e-06	1.95e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—EP300—lung cancer	2.59e-06	1.93e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—lung cancer	2.59e-06	1.93e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—lung cancer	2.58e-06	1.92e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—lung cancer	2.57e-06	1.92e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—lung cancer	2.56e-06	1.91e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—lung cancer	2.56e-06	1.91e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—lung cancer	2.52e-06	1.88e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—lung cancer	2.51e-06	1.87e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	2.48e-06	1.85e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—lung cancer	2.47e-06	1.84e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—lung cancer	2.47e-06	1.84e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—lung cancer	2.45e-06	1.83e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—lung cancer	2.45e-06	1.83e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—lung cancer	2.42e-06	1.8e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—lung cancer	2.41e-06	1.8e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—lung cancer	2.4e-06	1.79e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—lung cancer	2.4e-06	1.79e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—lung cancer	2.37e-06	1.77e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—lung cancer	2.36e-06	1.76e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—lung cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—lung cancer	2.32e-06	1.73e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—lung cancer	2.29e-06	1.71e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—lung cancer	2.26e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—lung cancer	2.22e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—lung cancer	2.22e-06	1.66e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—lung cancer	2.22e-06	1.65e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—EP300—lung cancer	2.21e-06	1.65e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—lung cancer	2.19e-06	1.64e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—lung cancer	2.18e-06	1.63e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—lung cancer	2.18e-06	1.62e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—lung cancer	2.1e-06	1.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—lung cancer	2.02e-06	1.51e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.93e-06	1.44e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—lung cancer	1.92e-06	1.43e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—lung cancer	1.91e-06	1.43e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—lung cancer	1.71e-06	1.28e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.63e-06	1.22e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—lung cancer	1.58e-06	1.18e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—lung cancer	1.56e-06	1.17e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—lung cancer	1.34e-06	9.96e-06	CbGpPWpGaD
